SunRISe-1 – Talk Bio

Actionable Insights Powered by AI

Johnson & Johnson’s Bladder Cancer Treatment Falls Short Against Chemoradiation

7 months ago talkbio0Tagged Chemoradiotherapy, Johnson and Johnson, Malignant neoplasm of urinary bladder, SunRISe-1, TAR 200

Johnson & Johnson, bladder cancer, chemoradiation, TAR-200, SunRISe-1 study